Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Adults with Splanchnic Vein Thrombosis: A Case-Control Study

被引:5
作者
Kollabathula, Arpitha [1 ]
Sharma, Saniya [2 ]
Kumar, Narender [2 ]
Ahluwalia, Jasmina [2 ]
Das, Reena [2 ]
Varma, Neelam [2 ]
Rana, Surinder Singh [3 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Pathol, Sect 12, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Hematol, Level 5,Res Block A,Sect 12, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Gastroenterol, Sect 12, Chandigarh 160012, India
关键词
Amplification refractory mutation system; Plasminogen activator inhibitor-1; PAI-1; 4G; 5G polymorphism; Splanchnic vein thrombosis; Thrombophilia; RISK-FACTORS; PAI-1; GENE; MTHFR; 677TT; V-LEIDEN; 4G-4G;
D O I
10.1007/s12288-021-01454-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of PAI-1 4G/5G polymorphism in venous thrombosis is unclear. PAI-1 4G/4G genotype is associated with elevated levels of PAI-1 resulting in a hypofibrinolytic state and hence increased thrombotic risk. In this study, we assessed the role of PAI-1 4G/5G promoter polymorphism in adult patients with splanchnic vein thrombosis. A total of 40 cases (portal vein thrombosis and Budd-Chiari syndrome) and 40 healthy controls were evaluated for the PAI-14G/5G polymorphism by amplification refractory mutation system polymerase chain reaction along with thrombophilia workup. The frequency of PAI-1 4G/4G homozygous, 4G/5G heterozygous and 5G/5G homozygous genotypes were 17.5%, 42.5% and 40%, respectively among cases and 22.5%, 50% and 27.5%, respectively among controls and the difference was not statistically significant (p = 0.61). The PAI-1 4G/4G genotype was significantly associated with the cases with deranged thrombophilic risk factor (both inherited and acquired) (p = 0.02).
引用
收藏
页码:169 / 172
页数:4
相关论文
共 12 条
[1]   Plasminogen Activator Inhibitor-1 (PAI-1) Gene 4G/5G Promoter Polymorphism is Seen in Higher Frequency in the Indian Patients With Deep Vein Thrombosis [J].
Akhter, Mohammed Suhail ;
Biswas, Arijit ;
Ranjan, Ravi ;
Meena, Arvind ;
Yadav, Birendra Kumar ;
Sharma, Amit ;
Saxena, Renu .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (02) :184-188
[2]   Inherited and Acquired Risk Factors for Venous Thromboembolism [J].
Baglin, Trevor .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 33 (02) :127-137
[3]   PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs [J].
Balta, G ;
Altay, C ;
Gurgey, A .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (02) :89-93
[4]   Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian population [J].
D'Amico, Mario ;
Pasta, Francesca ;
Pasta, Linda .
GENE, 2015, 568 (01) :85-88
[5]   Risk factors of thrombosis in abdominal veins [J].
Dutta, Amit Kumar ;
Chacko, Ashok ;
George, Biju ;
Joseph, Joseph Anjilivelil ;
Nair, Sukesh Chandran ;
Mathews, Vikram .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (28) :4518-4522
[6]  
Francis CW, 2002, ARCH PATHOL LAB MED, V126, P1401
[7]   PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data From Three Prospective Studies [J].
Pasta, Linda ;
Pasta, Francesca ;
D'Amico, Mario .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2016, 6 (01) :10-14
[8]   Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study [J].
Prabhudesai, Aniket ;
Shetty, Shrimati ;
Ghosh, Kanjaksha ;
Kulkarni, Bipin .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (03) :249-254
[9]   Clinical approach to splanchnic vein thrombosis: Risk factors and treatment [J].
Riva, Nicoletta ;
Donadini, Marco P. ;
Dentali, Francesco ;
Squizzato, Alessandro ;
Ageno, Walter .
THROMBOSIS RESEARCH, 2012, 130 :S1-S3
[10]   The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia [J].
Sartori, MT ;
Danesin, C ;
Saggiorato, G ;
Tormene, D ;
Simioni, P ;
Spiezia, L ;
Patrassi, GM ;
Girolami, A .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2003, 9 (04) :299-307